| Literature DB >> 35743844 |
José Augusto Rodrigues Santos1, Tiago Azenha Rama2,3, Domingos José Lopes da Silva4, Ricardo J Fernandes1,5, Rodrigo Zacca6,7.
Abstract
BACKGROUND: Physical exercise can affect the immune system. We studied the effect of antioxidants on hematological and immune biomarkers after heavy training.Entities:
Keywords: antioxidants; exercise; exercise physiology; firefighters; health; leukocytes; lymphocyte subsets; lymphocytes; micronutrients; nutrition; recruits; supplementation; training and testing
Year: 2022 PMID: 35743844 PMCID: PMC9225374 DOI: 10.3390/life12060813
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Figure 1Flow diagram of the study.
Age, toxic habits, and anthropometrical characteristics of the participants.
| Variables | Supplemented Group | Placebo Group (PG) |
|---|---|---|
| 22.1 ± 1.9 | 23.9 ± 0.3 | |
| 3 | 7 |
Data for age and anthropometrical characteristics are shown as mean and respective standard deviation. The differences between groups are not statistically significant (p > 0.05).
Figure 2Physical Training Program.
Results of physical fitness tests at baseline (mean ± SD) for both groups.
| Indicators | Supplemented Group (SG) | Placebo Group (PG) | |
|---|---|---|---|
| 12 ± 7 | 14 ± 6 | ||
| 16 ± 1 | 16 ± 2 | ||
| 7.0 ± 0.0 | 7.0 ± 0.1 | ||
| 3007 ± 127 | 3120 ± 106 | ||
|
| 10.5 ± 0.5 | 10.8 ± 0.1 | |
| 7.8 ± 0.5 | 8.1 ± 0.3 | ||
| 5.7 ± 0.8 | 5.8 ± 0.6 | ||
| 45.9 ± 6.4 | 45.2 ± 6.8 | ||
| 37.3 ± 5.7 | 37.8 ± 3.5 | ||
| 38.3 ± 6.2 | 39.4 ± 5.8 | ||
Differences between groups were not statistically significant (p > 0.05).
Nutritional intake at baseline (mean ± SD).
| Variables | Supplemented Group (SG) | Placebo Group (PG) |
|---|---|---|
| 3050 ± 600 | 2985 ± 580 | |
| 51.2 ± 5.8 | 50.8 ± 3.1 | |
| 18.4 ± 2.5 | 19.2 ± 2.1 | |
| 30.2 ± 3.3 | 30.8 ± 2.8 | |
| 147.2 ± 58.2 | 152.8 ± 47.3 | |
| 7.9 ± 2.3 | 8.3 ± 2.8 | |
| 165.1 ± 4.3 | 158.3 ± 7.2 | |
| 431.4 ± 76.8 | 411.9 ± 82.5 | |
| 163.3 ± 22.7 | 161.9 ± 54.2 | |
| 16.9 ± 5.7 | 17.1 ± 4.2 |
Differences between groups were not statistically significant (p > 0.05).
Cluster, clone, fluorescent stain, origin, and antibody specificity.
| Cluster | Fluorocrom | Clone | Origin | Main Cell Reactivity |
|---|---|---|---|---|
|
| FITC | SK 7 | Becton ** | T cells |
|
| PE | SK 3 | Beckman Coulter *** | Helper T cells |
|
| FITC | 2H4 | Beckman Coulter *** | Helper T naïve cells |
|
| PE | SK 1 | Becton ** | Cytotoxic T cells |
|
| FITC/PE | HNK-1, SK 1 | Becton ** | Cytotoxic T cells with no MHC restriction |
|
| FITC/PE | SK 7, B 73.1, My 31 | Becton ** | Natural Killer cells |
|
| FITC | 4 G 7 | Becton ** | B cells |
** Becton Dickinson, San José, Califórnia, USA; *** Beckman Coulter Diagnostics; Brea, California, USA; Isotype controls from Becton and Beckman Coulter were used.
Immune cell changes (mean ± SD) after 5-weeks for the supplemented group (SG).
| Indicators | M1 (Baseline) | M2 (after 5-Weeks) | |
|---|---|---|---|
| 5091.6 ± 956.8 | 5708.3 ± 1937.4 | 0.236, −0.40 “small” | |
| 38.2 ± 6.8 | 37.3 ± 12.0 | 0.796, 0.09 “trivial” | |
| 1914.4 ± 337.6 | 2000.1 ± 598.7 | 0.466, −0.17 “trivial” | |
|
| 72.8 ± 6.6 | 73.7 ± 7.9 | 0.445, −0.12 “trivial” |
|
| 41.3 ± 5.7 | 43.7 ± 8.0 | 0.055, −0.34 “small” |
|
| 4.4 ± 2.2 | 3.7 ± 2.6 | 0.079, 0.29 “small” |
|
| 27.7 ± 4.9 | 26.5 ± 4.6 |
|
|
| 41.8 ± 5.7 | 44.4 ± 8.1 |
|
|
| 32.1 ± 4.5 | 30.3 ± 4.8 |
|
|
| 10.6 ± 3.0 | 12.3 ± 3.4 |
|
|
| 15.9 ± 4.0 | 12.0 ± 4.8 |
|
|
| 1.5 ± 0.4 | 1.7 ± 0.5 |
|
Cells with a cluster of differentiation are expressed in percentage of lymphocytes.* Statistically significant differences (p < 0.05).
Immune cell changes (mean ± SD) after 5-weeks for the placebo group (PB).
| Indicators | M1 (Baseline) | M2 (after 5-Weeks) | |
|---|---|---|---|
| 5075.0 ± 1037.6 | 5741.7 ± 992.2 |
| |
| 37.5 ± 5.1 | 36.3 ± 4.5 | 0.425, 0.24 “small” | |
| 1901.8 ± 461.9 | 2082.2 ± 436.8 | 0.119, −0.40 “small” | |
|
| 74.9 ± 8.0 | 74.6 ± 8.1 | 0.834, 0.03 “trivial” |
|
| 43.9 ± 8.7 | 43.1 ± 7.3 | 0.489, 0.09 “trivial” |
|
| 3.5 ± 2.9 | 3.6 ± 2.7 | 0.727, −0.03 “trivial” |
|
| 26.9 ± 9.8 | 27.4 ± 9.6 | 0.165, −0.05 “trivial” |
|
| 44.4 ± 8.6 | 43.4 ± 7.3 | 0.580, 0.12 “trivial” |
|
| 30.3 ± 8.1 | 31.0 ± 7.8 | 0.140, −0.08 “trivial” |
|
| 12.6 ± 4.4 | 11.7 ± 4.5 | 0.072, 0.20 “small” |
|
| 11.9 ± 6.6 | 12.8 ± 5.9 |
|
|
| 1.9 ± 1.2 | 1.8 ± 1.0 | 0.076, 0.09 “trivial” |
Values are mean ± standard deviation. Cells with a cluster of differentiation are expressed in percentage of lymphocytes. * Statistically significant differences (p < 0.05).
Comparison between groups at baseline and after 5-weeks.
| Indicators | SG vs. PG | SG vs. PG |
|---|---|---|
| 0.968, 0.01 “trivial” | 0.958, −0.02 “trivial” | |
| 0.761, 0.11 “trivial” | 0.787, 0.11 “trivial” | |
| 0.940, 0.03 “trivial” | 0.705, −0.15 “trivial” | |
|
| 0.503, −0.28 “small” | 0.786, −0.11 “trivial” |
|
| 0.402, −0.35 “small” | 0.864, 0.07 “trivial” |
|
| 0.396, 0.34 “small” | 0.969, 0.03 “trivial” |
|
| 0.795, 0.10 “trivial” | 0.791, −0.11 “trivial” |
|
| 0.384, −0.35 “small” | 0.865, 0.12 “trivial” |
|
| 0.515, 0.27 “small” | 0.770, −0.10 “trivial” |
|
| 0.203, −0.53 “small” | 0.735, 0.15 “trivial” |
|
| 0.086, 0.73 “moderate” | 0.723, −0.14 “trivial” |
|
| 0.232, −0.44 “small” | 0.617, −0.12 “trivial” |
Supplemented group (SG) (n = 12). Placebo group (PG) (n = 12).
Body mass and body composition (mean ± SD) at baseline and after 5-weeks for both groups.
| Indicators | Supplemented Group (SG) | Placebo Group (PB) | |
|---|---|---|---|
| M1 | 68.9 ± 7.4 | 69.3 ± 12.3 | 0.439, −0.03 “trivial” |
| M2 | 69.2 ± 7.2 | 69.5 ± 10.8 | 0.562, −0.03 “trivial” |
| M1 | 9.6 ± 2.0 | 10.2 ± 2.0 | 0.786, −0.29 “small” |
| M2 | 9.7 ± 2.1 | 10.0 ± 1.9 | 0.882, −0.14 “trivial” |